GEN Exclusives

More »

GEN News Highlights

More »
Aug 19, 2008

ArunA Obtains Commercialization Rights to Univ. of Georgia's Human Mesenchymal Stem Cells

  • ArunA Biomedical gained a license that allows it to commercialize human mesenchymal cells (hMSC™) developed at the University of Georgia Research Foundation. These hMSCs are derived from human embryonic stem cells.

    ArunA reports that it will offer the academic and industrial research communities access to a highly uniform population of human mesenchymal cells grown as adherent monolayer cultures in multiple turn-key kit formats.

    “We are targeting an early first quarter 2009 launch of ArunA's first hMSC kit,”  says William Sharp, president and CEO.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Mindclones and Immortality

Is the idea of making a software copy of a human mind something in the realm of reality or science fiction?